Glenmark Pharmaceuticals Ltd Q4 FY2024-2025 Results: Summary
Revenue | ₹3,267.89Cr |
Net Profits | ₹4.65Cr |
Net Profit Margins | 0.14% |
Glenmark Pharmaceuticals Ltd’s revenue fell -15.35% since last year same period to ₹3,267.89Cr in the Q4 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -4.41% fall in its revenue since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit jumped 100.38% since last year same period to ₹4.65Cr in the Q4 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -98.66% fall in its net profits since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit margin jumped 100.45% since last year same period to 0.14% in the Q4 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -98.6% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Glenmark Pharmaceuticals Ltd in Q4 results 2024?
The revenue for Glenmark Pharmaceuticals Ltd in the Q4 results 2024 was ₹3,267.89Cr.
What was the net profit for Glenmark Pharmaceuticals Ltd in Q4 results 2024?
The net profit for Glenmark Pharmaceuticals Ltd in the Q4 results 2024 was ₹4.65Cr.
What was the net profit margin for Glenmark Pharmaceuticals Ltd in Q4 results 2024?
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q4 results 2024 was 0.14%.
What was the revenue for Glenmark Pharmaceuticals Ltd in Q4 results 2023?
The revenue for Glenmark Pharmaceuticals Ltd in the Q4 results 2023 was ₹3,860.49Cr.
What was the net profit for Glenmark Pharmaceuticals Ltd in Q4 results 2023?
The net profit for Glenmark Pharmaceuticals Ltd in the Q4 results 2023 was ₹-1218.28Cr.
What was the net profit margin for Glenmark Pharmaceuticals Ltd in Q4 results 2023?
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q4 results 2023 was -31.56%.
